发明名称 |
Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases |
摘要 |
The present invention refers to a pharmaceutical composition that includes an active ingredient, such as a peptide, which acts as an antagonist and/or inverse agonist of a G protein-coupled receptor and pharmaceutically acceptable vehicle. The pharmaceutical composition may be used for the treatment of obesity and the prevention of and the treatment of diabetes. |
申请公布号 |
US9452196(B2) |
申请公布日期 |
2016.09.27 |
申请号 |
US201514703466 |
申请日期 |
2015.05.04 |
申请人 |
Sociedade Beneficente de Senhoras Hospital Sirio Libanes |
发明人 |
Heimann Andrea Sterman;Dale Camila Squarzoni;Devi Lakshmi A. |
分类号 |
A61K38/00;A61P3/04;A61K38/08;A61K38/42;A61K45/06;C07K7/06 |
主分类号 |
A61K38/00 |
代理机构 |
Alston & Bird LLP |
代理人 |
Alston & Bird LLP |
主权项 |
1. A pharmaceutical composition for the treatment of obesity, comprising: hemopressin and a pharmaceutically acceptable vehicle, said pharmaceutical composition provides a reduction of body fat, and wherein the hemopressin is defined by amino acid sequence proline-valine-asparagine-phenylalanine-lysine-tryptophan-leucine-serine-histidine (SEQ ID NO:7). |
地址 |
Sao Paulo BR |